Biochemistry

Distinguished Speakers

2018

Dr. Gary S. Shaw, University of Western Ontario
The Structural Biology of Proteins In Early-Onset Parkinson’s Disease; From Inhibition to Activation
June 15
Dr. Frank Sönnichsen, Christian-Albrechts-Universität zu Kiel, Germany
Protein Engineering without NCE

Dr. Heather Dettman
, Natural Resources Canada,
NMR Spectroscopy and Petroleum

Dr. Joe O’Neil
, University of Manitoba
Solubility Problems with Disordered Proteins

Dr. Jim Baleja
, Tufts University
Epidermal Metabolomics
 
Patricia Campbell Ph.D., Partner at Jones Day
The Role of Patents in Biotechnology

Dr. Krishna Rajarathnam
, University of Texas Medical Branch Galveston
Chemokine Monomers and Dimers: 25 Years Later. 

Dr. Matt Crump
, University of Bristol, UK
‘Always pick a system’ - Brian D. Sykes, Nucleus Meeting, 1998.

Dr. JianJun Wang
, Wayne State University 
Kill or no-Kill, A Choice for a New Cancer Therapy

Dr. Campbell McInnes
, University of South Carolina
Inhibitors of B-Raf Kinase Block Dimerization and Overcome Paradoxical MEK/ERK Activation

Dr. Xu Wang
, Arizona State University
NMR Studies of Glycosaminoglycan Binding Proteins

Dr. Tharin Blumenschein
, University of East Anglia, UK
Intrinsically Disordered Proteins

Dr. Jan Rainey
, Dalhousie University
Applying Fluorotryptophan Probes to Characterize Spider Silk and Membrane Proteins.
 
Dr. David Sykes, Massachusetts General Hospital
The Humble Neutrophil: What Are They Good For Anyway?

Dr. Sam Sia
, Columbia University
Miniaturization for Next-generation Diagnostics and Therapeutics. 

Dr. Lewis Kay
, University of Toronto
It All Started Here: Spins, Proteins, and Magnets
 
June 14
Dr. Malcolm Irving, King's College London, UK and Francis Crick Institute, London, UK
Regulation of Contraction in Skeletal Muscle and in the Heart
June 13
Dr. Wayne Chen, University of Calgary
Ryanodine Receptor Store Ca2+ regulation: from Structure to Cardiac and Neurological Disorders
May 24
Dr. Grant Kemp, Stockholm University
Two's company: Cooperativity in co-translational protein folding
April 6

2017

Dr. John Pascal, Université de Montréal
Structural biology of poly(ADP-ribose) polymerase enzymes and the cellular response to DNA damage
November 28
Dr. Timothy Durrett, Kansas State University
From Burning Bushes to Chocolate Vines: Using Sequence Diversity to Explore MBOAT Substrate Specificity and Increase Production of Low Viscosity Oil
September 28
Dr. Voula Kanelis, University of Toronto, Mississauga
The effect of regulatory interactions and disease mutations on the NBDs of SUR proteins, the regulatory subunits in KATP channels
September 8
Dr. Randall Cohrs, University of Colorado, Denver
Varicella zoster virus: a 31 year journey involving autopsies and astronauts
August 29
Dr. Stephen Young, University of California, Los Angeles
Discovery, design and development of human amylase inhibitors: from nM to pM
August 25

Dr. Miroslaw Cygler, University of Saskatchewan
Structure, function and dynamics of the mitochondrial Fe/S cluster synthesis complex
August 11

Dr. Charles Sanders, Vanderbuilt University
The Scarlet Letter: The Role of Membrane Proteine Misfolding in Charcot-Marie-Tooth Disease
June 23
Dr. Randy Read, University of Cambridge
An unexpected crystallographic insight into renin secretion
June 15
Dr. Natalie Strynadka, UBC
Hybrid structural methods to probe transport assemblies on the bacterial membrane
June 15
Dr. Amir Khan, Trinity College, Ireland
Poxvirus antagonism of host innate immunity
June 15
Dr. Reinhart Reithmeier, University of Toronto
Folding and Misfolding of membrane proteins: the red cell Band 3 anion exhcanger in human health and disease
April 27
Dr. Brian Mark, University of Manitoba
Corrupting the ubiquitin system: a virual strategy to evade host immunity
March 17